Results 261 to 270 of about 2,386,057 (296)

Corporate law and corporate psychopaths

Psychiatry, Psychology and Law, 2020
For more than three decades there has been a growing interest, and concern, in the role that psychopathy plays in corporate affairs. The literature in this field is essentially interdisciplinary, drawing heavily on advances in neuroscience, behavioural and organisational psychology and criminology.
Sheehy, Benedict, Boddy, Clive, Murphy, Brendon   +2 more
openaire   +5 more sources

Corporate Debt and Corporate Taxes

The Journal of Finance, 1979
CORPORATIONS MAY ISSUE VARIOUS types of financial contracts to investors. The market price of each security depends upon its claim on corporate resources and its influence on taxes. Modigliani and Miller [5, 6] and Cox and Ross [2] elaborate an arbitrage theory of security valuation.
Bierman, Harold, Jr, Oldfield, George S, Jr   +1 more
openaire   +1 more source

Corporate identity, corporate branding and corporate reputations

European Journal of Marketing, 2012
PurposeThe main purpose of this paper is to explore, define, reconcile and depict corporate identity (CI), corporate brand (CB) and corporate reputation (CR) in a framework that reflects the dimensions of these constructs, discriminates between them and represents their inter‐relatedness.Design/methodology/approachThe paper draws on key literature ...
Abratt, Russell, Kleyn, Nicola Susan
openaire   +2 more sources

Corporate Imagery and Corporate Identity

1994
In any organization, the relationship between strategic, structural, and psychological factors centering around a common core of abilities leads us to postulate the existence of a “corporate identity” which, in the same way as an individual’s personality, deeply influences its development.
Larçon, Jean-Paul, Reitter, Roland
openaire   +2 more sources

Corporate Finance and Corporate Governance

The Journal of Finance, 1988
ABSTRACTA combined treatment of corporate finance and corporate governance is herein proposed. Debt and equity are treated not mainly as alternative financial instruments, but rather as alternative governance structures. Debt governance works mainly out of rules, while equity governance allows much greater discretion.
openaire   +1 more source

XYZ Corporation and Corporate Entrepreneurship

Darden Business Publishing Cases, 2008
After more than 40 years of focus on a single related technology platform, XYZ Corp. had begun trying to foster an entrepreneurial climate within the organization. Its goal? To develop vibrant new ventures through a program called “Growing Green Businesses.” As XYZ's main product lines were becoming commoditized and several billion dollars in free cash
openaire   +1 more source

Corporate Governance and Corporate Agility

SSRN Electronic Journal, 2019
Most of the extensive literature on corporate governance during the past fifty years has approached the topic from the perspective of agency theory and it has focused on dimensions of governance that are relatively easy to measure (e.g., ownership structure, size and structure of boards, executive compensation).
openaire   +1 more source

Corporate Governance and Corporate Identity*

Corporate Governance: An International Review, 2006
The aim of this paper is to discuss and analyse whether recommendations on corporate governance have led to more transparency and well‐defined corporate identities for listed small and medium‐sized companies through their external communication on corporate governance.
openaire   +2 more sources

CORPORAL PUNISHMENT

Pediatric Clinics of North America, 1998
Pediatricians differ on the optimal ways to discipline children. The major controversy surrounds the use of corporal punishment. In an effort to resolve this controversy, the American Academy of Pediatrics (AAP) cosponsored a conference entitled "The Short and Long-Term Consequences of Corporal Punishment" in February 1996.
L J, Bauman, S B, Friedman
openaire   +2 more sources

Gentris Corporation

Pharmacogenomics, 2002
Gentris Corporation is engaged in the development and rapid commercialization of innovative proprietary clinical pharmacogenomic products and services. The company provides global pharmaceutical research organizations with turn-key pharmacogenomic solutions to improve the efficiency and predictability of drug development.
openaire   +2 more sources